Zai Lab Ltd
ZLAB
44 insider filings · Latest: Aug 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Aug 13 8:15 PM | William LisDirector | Sale | 8,506 | $25.00 | $212.7K | 41,931(D) | View → |
| Aug 11, 2026 | Aug 13 8:15 PM | Yajing ChenChief Financial Officer | Sale | 619 | $25.00 | $15.5K | 35,072(D) | View → |
| Aug 12, 2026 | Aug 12 2:42 PM | Lis William | Proposed Sale | 8,506 | $25.00 | $212.7K | — | View → |
| Aug 11, 2026 | Aug 11 8:22 PM | Chen Yajing | Proposed Sale | 619 | $25.00 | $15.5K | — | View → |
| Jul 1, 2026 | Jul 6 8:14 PM | Richard GaynorDirector | Purchase | 1,736 | $19.05 | $33.1K | 80,737(D) | View → |
| Jun 30, 2026 | Jul 1 8:24 PM | Ying DuDirector, Chairperson & CEO | Sale | 7,026 | $18.53 | $130.2K | 1,203,784(D) | View → |
| Jun 30, 2026 | Jun 30 7:13 PM | Du Ying | Proposed Sale | 7,026 | $18.53 | $130.2K | — | View → |
| Jun 26, 2026 | Jun 29 8:18 PM | Frazor Titus Edmondson IIIChief Legal Officer | Sale | 4,103 | $17.46 | $71.6K | 30,346(D) | View → |
| Jun 26, 2026 | Jun 29 8:17 PM | Ying DuDirector, Chairperson & CEO | Sale | 24,543 | $17.46 | $428.5K | 1,192,840(D) | View → |
| Jun 26, 2026 | Jun 29 8:17 PM | Yajing ChenChief Financial Officer | Sale | 2,264 | $17.46 | $39.5K | 35,691(D) | View → |
| Jun 26, 2026 | Jun 26 7:38 PM | Chen Yajing | Proposed Sale | 2,264 | $17.46 | $39.5K | — | View → |
| Jun 26, 2026 | Jun 26 7:18 PM | Edmondson Frazor Titus III | Proposed Sale | 4,103 | $17.46 | $71.6K | — | View → |
| Jun 26, 2026 | Jun 26 7:12 PM | Du Ying | Proposed Sale | 24,543 | $17.46 | $428.6K | — | View → |
| Jun 22, 2026 | Jun 24 8:05 PM | William LisDirector | Sale | 7,040 | $18.09 | $127.4K | 50,437(D) | View → |
| Jun 22, 2026 | Jun 22 2:10 PM | Lis William | Proposed Sale | 7,040 | $18.09 | $127.4K | — | View → |
| May 18, 2026 | May 19 8:18 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.00 | $949.8K | 1,122,626(D) | View → |
| May 15, 2026 | May 19 8:18 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $20.74 | $1.0M | 1,122,626(D) | View → |
| May 18, 2026 | May 18 3:34 PM | Du Ying | Proposed Sale | 50,000 | $19.52 | $976.0K | — | View → |
| May 14, 2026 | May 15 8:46 PM | Frazor Titus Edmondson IIIChief Legal Officer | Sale | 3,517 | $20.19 | $71.0K | 19,849(D) | View → |
| May 14, 2026 | May 15 8:45 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $20.09 | $1.0M | 1,122,626(D) | View → |
Page 1 of 6
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 3 9:58 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 14,200 | — | 0(D) | View → |
| Mar 4, 2026 | Apr 3 9:58 PM | Ying DuDirector, Chairperson & CEO | Grant/Award | 25,579 | — | 25,579(D) | View → |
| Apr 2, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Option Exercise | 2,500 | — | 2,500(D) | View → |
| Apr 1, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Option Exercise | 15,258 | — | 27,516(D) | View → |
| Mar 4, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Grant/Award | 11,924 | — | 11,924(D) | View → |
| Apr 2, 2026 | Apr 3 9:57 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Option Exercise | 5,391 | — | 5,391(D) | View → |
| Apr 1, 2026 | Apr 3 9:57 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Option Exercise | 19,523 | — | 39,046(D) | View → |
| Mar 4, 2026 | Apr 3 9:57 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Grant/Award | 14,905 | — | 14,905(D) | View → |
| Mar 12, 2026 | Mar 16 8:09 PM | Joshua L SmileyPresident and Chief Operating Officer | Option Exercise | 6,388 | — | 19,165(D) | View → |
| Mar 4, 2026 | Mar 16 8:09 PM | Joshua L SmileyPresident and Chief Operating Officer | Grant/Award | 137,733 | $19.27 | 33,783(D) | View → |
| Mar 12, 2026 | Mar 16 8:08 PM | Frazor Titus Edmondson IIIChief Legal Officer | Option Exercise | 4,258 | — | 12,777(D) | View → |
| Mar 4, 2026 | Mar 16 8:08 PM | Frazor Titus Edmondson IIIChief Legal Officer | Grant/Award | 110,187 | $19.27 | 27,027(D) | View → |
| Mar 12, 2026 | Mar 16 8:08 PM | Yajing ChenChief Financial Officer | Option Exercise | 4,258 | — | 12,777(D) | View → |
| Mar 4, 2026 | Mar 16 8:08 PM | Yajing ChenChief Financial Officer | Grant/Award | 110,187 | $19.27 | 27,027(D) | View → |
| Mar 12, 2026 | Mar 16 8:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Option Exercise | 5,323 | — | 15,971(D) | View → |
| Mar 4, 2026 | Mar 16 8:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Grant/Award | 137,733 | $19.27 | 33,783(D) | View → |
| Mar 11, 2026 | Mar 16 8:06 PM | Ying DuDirector, Chairperson & CEO | Grant/Award | 385,849 | $19.34 | 32,419(D) | View → |
| Mar 10, 2026 | Mar 12 8:12 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 263,747 | $1.74 | 7,965(D) | View → |
| Mar 9, 2026 | Mar 10 8:08 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 722,184(D) | View → |
| Mar 6, 2026 | Mar 10 8:08 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 772,184(D) | View → |